Impact of COVID-19 on chronic migraine treated with erenumab: a case report

BACKGROUND: Headache is a frequent symptom of the novel coronavirus 19 disease (COVID-19). To date, there are limited information on how COVID-19 affects migraine and its treatment. CASE DESCRIPTION: A 47-year-old patient, suffering from chronic migraine and medication-overuse headache, in September...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassini, Alberto, Marcinnò, Andrea, Roveta, Fausto, Gallo, Erica, Cermelli, Aurora, Boschi, Silvia, Rubino, Elisa, Rainero, Innocenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139216/
https://www.ncbi.nlm.nih.gov/pubmed/34021438
http://dx.doi.org/10.1007/s10072-021-05329-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139216/
https://www.ncbi.nlm.nih.gov/pubmed/34021438
http://dx.doi.org/10.1007/s10072-021-05329-5

Ejemplares similares